EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+9.23%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.08B
AUM Growth
+$5.08B
(+8.7%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
6.03%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$78M |
| 2 |
Biohaven
BHVN
|
$74.9M |
| 3 |
Doximity
DOCS
|
$57.4M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$55.8M |
| 5 |
DoubleVerify
DV
|
$50.5M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$165M |
| 2 |
Cogent Biosciences
COGT
|
$33.3M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$33.2M |
| 4 |
Duolingo
DUOL
|
$33.1M |
| 5 |
Kura Oncology
KURA
|
$32.8M |
Sector Composition
| 1 | Healthcare | 38.81% |
| 2 | Technology | 25% |
| 3 | Industrials | 15.64% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Utilities | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Clearway Energy Class C
CWEN
$3.51B
| $36.4M | 0.72% | 1,141,486 +299,086 | +36% | +$9.53M |
|
52
Zymeworks
ZYME
$1.12B
| $33.1M | 0.65% | 5,380,200 | – | – |
|
53
Lattice Semiconductor
LSCC
$9.09B
| $31.4M | 0.62% | 638,544 -12,000 | -2% | -$591K |
|
54
Immunovant
IMVT
$2.56B
| $30M | 0.59% | 5,372,512 | – | – |
|
|
BPMC
55
DELISTED
Blueprint Medicines
BPMC
| $28.9M | 0.57% | 438,500 | – | – |
|
56
ASML
ASML
$292B
| $28.7M | 0.56% | 69,086 +86 | +0.1% | +$35.7K |
|
57
Coursera
COUR
$1.88B
| $28.6M | 0.56% | 2,654,716 +15,623 | +0.6% | +$168K |
|
58
TSMC
TSM
$1.2T
| $28.2M | 0.56% | 411,827 +1,827 | +0.4% | +$125K |
|
59
908 Devices
MASS
$226M
| $28.2M | 0.56% | 1,715,801 +217,700 | +15% | +$3.58M |
|
60
nVent Electric
NVT
$14.5B
| $27.6M | 0.54% | 873,300 +14,100 | +2% | +$446K |
|
61
Verisk Analytics
VRSK
$37.5B
| $26.9M | 0.53% | 157,800 | – | – |
|
62
Mirum Pharmaceuticals
MIRM
$3.71B
| $26.8M | 0.53% | +1,275,000 | New | +$26.8M |
|
63
Brookfield Renewable
BEPC
$6.05B
| $25.3M | 0.5% | 775,019 | – | – |
|
64
Neurocrine Biosciences
NBIX
$13.8B
| $25M | 0.49% | 235,000 | – | – |
|
65
Nasdaq
NDAQ
$54.4B
| $24.8M | 0.49% | 437,225 +317,325 | +265% | +$18M |
|
66
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
| $24.6M | 0.48% | 822,664 | – | – |
|
67
Rexford Industrial Realty
REXR
$9.8B
| $23.9M | 0.47% | 460,209 -41,084 | -8% | -$2.14M |
|
68
Apellis Pharmaceuticals
APLS
$3.48B
| $23.2M | 0.46% | +339,355 | New | +$23.2M |
|
69
Steris
STE
$24.1B
| $23.2M | 0.46% | 139,352 +27,167 | +24% | +$4.52M |
|
70
Xenon Pharmaceuticals
XENE
$2.98B
| $23.1M | 0.46% | 641,200 +171,500 | +37% | +$6.19M |
|
71
Annexon
ANNX
$226M
| $22.4M | 0.44% | 3,626,508 | – | – |
|
72
CDW
CDW
$21.6B
| $22.3M | 0.44% | 142,700 +60,100 | +73% | +$9.38M |
|
73
Repligen
RGEN
$6.88B
| $22.3M | 0.44% | 119,000 | – | – |
|
74
Williams Companies
WMB
$70.7B
| $21.6M | 0.42% | 752,900 +35,200 | +5% | +$1.01M |
|
|
BCYC
75
Bicycle Therapeutics
BCYC
$511M
| $19.9M | 0.39% | 853,800 | – | – |
|